• GSK and IDEAYA partner in synthetic lethality pharmatimes
    June 18, 2020
    GlaxoSmithKline and IDEAYA Biosciences have announced a strategic partnership in synthetic lethality, an emerging arm of oncology and a core research focus for GSK.
PharmaSources Customer Service